Obeso JA - Search Results

1

[Entacapone: is it useful as complimentary treatment with levodopa?].

Burguera JA, Grandas F, Horga de la Parte JF, Luquin R, Martí F, Matías-Guiu J, Obeso JA, Kulisevsky J. Burguera JA, et al. Among authors: obeso ja. Rev Neurol. 1999 Apr 16-30;28(8):817-34. Rev Neurol. 1999. PMID: 10363328 Spanish.

2

[Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].

Castro A, Valldeoriola F, Linazasoro G, Rodriguez-Oroz MC, Stochi F, Marin C, Rodriguez M, Vaamonde J, Jenner P, Alvarez L, Pavon N, Macias R, Luquin MR, Hernandez B, Grandas F, Gimenez-Roldan S, Tolosa E, Obeso JA. Castro A, et al. Among authors: obeso ja. Neurologia. 2005 May;20(4):180-8. Neurologia. 2005. PMID: 15891947 Review. Spanish.

3

The role of pulsatile versus continuous dopamine receptor stimulation for functional recovery in Parkinson's disease.

Obeso JA, Grandas F, Herrero MT, Horowski R. Obeso JA, et al. Eur J Neurosci. 1994 Jun 1;6(6):889-97. doi: 10.1111/j.1460-9568.1994.tb00584.x. Eur J Neurosci. 1994. PMID: 7952277 Review.

4

Continuous dopaminergic stimulation in Parkinson's disease.

Obeso JA, Luquin MR, Vaamonde J, Grandas F, Martinez Lage JM. Obeso JA, et al. Can J Neurol Sci. 1987 Aug;14(3 Suppl):488-92. doi: 10.1017/s0317167100037963. Can J Neurol Sci. 1987. PMID: 3676922

5

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N. Rodriguez-Oroz MC, et al. Among authors: obeso ja. Brain. 2005 Oct;128(Pt 10):2240-9. doi: 10.1093/brain/awh571. Epub 2005 Jun 23. Brain. 2005. PMID: 15975946 Clinical Trial.

6

Subthalamotomy improves MPTP-induced parkinsonism in monkeys.

Guridi J, Herrero MT, Luquin R, Guillen J, Obeso JA. Guridi J, et al. Among authors: obeso ja. Stereotact Funct Neurosurg. 1994;62(1-4):98-102. doi: 10.1159/000098603. Stereotact Funct Neurosurg. 1994. PMID: 7631095

7

Levodopa in the treatment of Parkinson's disease: a consensus meeting.

Agid Y, Ahlskog E, Albanese A, Calne D, Chase T, De Yebenes J, Factor S, Fahn S, Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P, Marsden D, Melamed E, Michel PP, Mizuno Y, Obeso J, Oertel W, Olanow W, Poewe W, Pollak P, Tolosa E, et al. Agid Y, et al. Mov Disord. 1999 Nov;14(6):911-3. doi: 10.1002/1531-8257(199911)14:6<911::aid-mds1001>3.0.co;2-h. Mov Disord. 1999. PMID: 10584663 Review. No abstract available.

8

Early administration of entacapone prevents levodopa-induced motor fluctuations in hemiparkinsonian rats.

Marin C, Aguilar E, Bonastre M, Tolosa E, Obeso JA. Marin C, et al. Among authors: obeso ja. Exp Neurol. 2005 Mar;192(1):184-93. doi: 10.1016/j.expneurol.2004.10.008. Exp Neurol. 2005. PMID: 15698633

9

Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes.

Marin C, Aguilar E, Mengod G, Cortés R, Rodríguez-Oroz MC, Obeso JA. Marin C, et al. Among authors: obeso ja. Neurobiol Dis. 2008 Dec;32(3):340-8. doi: 10.1016/j.nbd.2008.07.019. Epub 2008 Aug 5. Neurobiol Dis. 2008. PMID: 18722529 Free article.

10

[Physiopathology of Parkinson disease].

Obeso JA, Rodríguez Oroz MC, Rodríguez Díaz M. Obeso JA, et al. Neurologia. 1998;13 Suppl 1:19-29. Neurologia. 1998. PMID: 9859682 Review. Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

464 results

Search Page